{"prompt": "['Simultaneous mRNA COVID-19 and IIV4 Vaccination Study', 'Version 2.0', 'September 17, 2021', 'days post each vaccination visit according to severity', 'and system organ classification', 'The proportion of participants in each vaccination group', 'with an adverse event of special interest occurring', 'during the study period according to event type', 'Comparison between vaccination groups of the mean', 'maximal change in score from baseline on the', 'EuroQOL 5 dimensions-5 level (EQ-5D-5L) and', 'EuroQOL visual analogue scale (EQ VAS) within 1-7', 'days following the first vaccination visit', 'To compare primary, secondary, and exploratory', 'outcomes 1a, 2a, 2b, 2c and 2d according to baseline', 'COVID-19 serostatus within each group', '-', 'The proportion of participants in each vaccination group', 'with a seroprotective HAI titer (> 1:40) pre- and post-', 'IIV4 immunization for each IIV4 antigen', 'The proportion of participants in each vaccination group', 'achieving seroconversion following IIV4 (an HAI titer >', '1:40 following IIV4 if the baseline titer is < 1:10 or a', 'four-fold rise in HAI titer if the baseline titer is > 1:10)', 'for each IIV4 antigen', '-', 'The geometric mean HAI titer (GMT) for each IIV4', 'antigen pre- and post-IIV4 in each vaccination group', '-', 'The geometric mean fold rise (GMFR) in HAI titer for', 'each vaccination group', '*Exploratory outcome measures regarding serum', 'antibody analyses will be included in a future protocol', 'amendment.', 'Estimated Time to Complete', 'Enrollment:', 'Approximately 6 months for enrollment', '9']['Simultaneous mRNA COVID-19 and IIV4 Vaccination Study', 'Version 2.0', 'September 17, 2021', '1 BACKGROUND', '1.1 Background', 'COVID-19', 'Coronavirus disease 2019 (COVID-19) is caused by a coronavirus called Severe Acute', 'Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). COVID-19 was first noted in late 2019', 'among clusters of pneumonia cases occurring in Wuhan China. The virus spread globally, in a', 'rapid manner, with the first case among a US resident reported in January 2020 1. On March', '11, the World Health Organization declared COVID-19 a pandemic 2. During the course of', '2020, the pandemic occurred in three distinct waves in the US, with the most recent and severe', 'wave starting in the fall of 2020 and persisting into early 2021. As of September 1st, 2021, over', '39 million COVID-19 cases and over 600,000 deaths have been reported in the United States3,', 'making this the worst pandemic to occur in this country since the 1918 Spanish flu. With the', 'recent emergence of the B.1.1.7, B.1.351, P.1, B.1.427, B.1.429 and other COVID-19 viral', 'variants of concern and interest in the US, the trajectory of the current remains uncertain 4', 'Typical symptoms of COVID-19 include fever, chills, cough, shortness of breath, difficulty', 'breathing, fatigue, myalgia, body aches, headache, new loss of taste or smell, sore throat,', 'congestion, runny nose, nausea, vomiting, and diarrhea. Complications of COVID-19 are varied', 'and include pneumonia, acute respiratory failure, acute respiratory distress syndrome, acute', 'liver, kidney and/or cardiac injury, secondary infections, septic shock, disseminated', 'intravascular coagulation, blood clots, multisystem inflammatory syndrome in children and', 'adults, rhabdomyolysis and neurologic symptoms. Among known risk factors for severe illness', 'are advanced age, cancer, chronic kidney disease, chronic obstructive pulmonary disease,', 'Down syndrome, obesity, serious heart conditions (heart failure, coronary artery disease or', 'cardiomyopathies), immunocompromised state from solid organ transplant, sickle cell disease', 'and type 2 diabetes mellitus, smoking and pregnancy 5', 'Influenza', 'Epidemic influenza is a highly infectious disease that occurs annually throughout the temperate', 'regions in both hemispheres in their respective winter months 6. Influenza infection occurs in all', 'age groups and is a major public health threat, as it has the ability to spread rapidly through', 'populations and affect a large number of people. While infection rates are generally highest', 'among school age children, the highest rates of serious morbidity and mortality occur among', 'individuals over 65 years of age and in children less than 1 year of age 7 Underlying medical', 'conditions such as chronic cardiac, pulmonary, kidney and metabolic disorders, and various', 'types of immunosuppression increase the likelihood of potential complications.', 'Uncomplicated influenza illness is characterized by the abrupt onset of constitutional symptoms', 'including: fever, myalgia, headache, malaise, nonproductive cough, sore throat, and rhinitis.', 'Influenza virus infection can also lead to more serious illness such as primary viral pneumonia', 'and exacerbation of underlying medical conditions. Common complications include bacterial', 'pneumonia, sinusitis, and otitis media. The estimated annual number of influenza-associated', 'hospitalizations in the United States is 226,000 and the estimated annual number of deaths is', '34,470 9,10 Hospitalizations due to influenza are typically more prevalent in seasons during', 'which A(H3N2) subtype predominates.', '10']\n\n###\n\n", "completion": "END"}